Events

The Kirby Institute is pleased to present: Megan Williams - "Reducing risks for reincarceration: Findings from research on the roles of Aboriginal Elders and service providers." Location: The Kirby Institute Level 6 Seminar Room, ...

Kirby Institute is pleased to present: Professor Rodney Phillips - "HIV and Darwinism." Biography : "Prof. Phillips works on the evolution of HIV. HIV is one of the most variable infectious agents ever studied.

Kirby Institute is pleased to present: Amit Achhra - “Risk, risk factors and management strategies of CVD and CKD in HIV: recent developments." : Cardiovascular and chronic kidney disease (CVD and CKD) are one of the major long-term ...

Kirby Institute is pleased to present: Chan Phetsouphanh - "Novel approaches to the characterization of antigen-specific CD4+ T cells in HIV-1 infection."   :  Immune reconstitution is typical in chronic HIV-1 infected ...

Kirby Institute is pleased to present: Professor Kimberly Page - "Testing a prophylactic HCV vaccine: the needs and realities of a clinical trial in injecting drug users." :  The hepatitis C virus (HCV) virus epidemic is ...

Stephen Wright - "Antiretroviral therapies and treatment-realated outcomes for HIV positive patients in Australia."   :  In the absence of a cure, the management, treatment, and monitoring of HIV disease is likely to be life ...

Where the marginal matters: Strengthening trans-disciplinary connections in postgraduate health research on sex, drugs and risk   The annual Postgraduate Research Symposium will seek to facilitate new connections between students ...

Professor David Cooper - "Antiretroviral therapy." :  Combination therapy has saved countless lives. However, we know it to be imperfect and we are always looking for ways to improve outcomes.

Skye McGregor - "Health research capacity building: what is it and how do we measure it?" :  Health improvement in developing countries depends on research that is locally relevant, meets the priority needs of populations and ...

Professor Lisa Maher - "Opioid substitution treatment protects against hepatitis C virus acquisition in people who inject drugs: The HITS-c study." : Background: While evidence of the effectiveness of opioid substitution treatment ...